Search

everythinglearnresearchcommunity

for

Search:↓

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Spironolactone most effective for hirsutism, but has side effects.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Neurosteroids show promise for treating epilepsy and more research is needed.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

All three treatments reduce hirsutism, but spironolactone works best long-term.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.